Ignite Creation Date:
2025-12-25 @ 2:04 AM
Ignite Modification Date:
2026-04-17 @ 8:41 AM
Study NCT ID:
NCT02739360
Status:
TERMINATED
Last Update Posted:
2020-03-04
First Post:
2016-04-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Roll Over Study to Provide Idelalisib to Participants Previously Treated With the Investigational PI3Kδ Inhibitor, GS-9820
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-05-04
Start Date Type:
ACTUAL
Primary Completion Date:
2017-12-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-12-28
Completion Date Type:
ACTUAL
First Submit Date:
2016-04-12
First Submit QC Date:
None
Study First Post Date:
2016-04-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-12-17
Results First Submit QC Date:
None
Results First Post Date:
2019-01-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-02-18
Last Update Post Date:
2020-03-04
Last Update Post Date Type:
ACTUAL